Drug Trial Radar · NCT06771271
A Study to Investigate RO7200220 as Monotherapy and in Combination With Ranibizumab in Participants With Diabetic and Uveitic Macular Edema
Last checked: Nov 20, 2026Latest source record: Jan 13, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
85
Actual
Start
Jul 22, 2019
Primary completion
Nov 13, 2023
Study completion Nov 13, 2023
Sponsor
- Lead sponsor
- Hoffmann-La RocheRoche (Genentech) (RHHBY)
- Sponsor type
- Industry
- First posted
- Jan 13, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study was to assess the safety and tolerability of RO7200220 as monotherapy (diabetic macular edema \[DME\] or uveitic macular edema \[UME\] population) and in combination with ranibizumab (DME population only).
Conditions
- Diabetic Macular Edema
- Uveitic Macular Edema
Interventions
RO7200220Drug
RO7200220 was administered as IVT injection.
RanibizumabDrug
Ranibizumab was administered as IVT injection.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Part 1: Number of Participants With Adverse Events (AEs)Time frame: Up to 18 weeks
- Part 2: Number of Participants With Adverse Events (AEs)Time frame: Up to 24 weeks
- Part 3: Number of Participants With Adverse Events (AEs)Time frame: Up to 20 weeks
- Part 4: Number of Participants With Adverse Events (AEs)Time frame: Up to 36 weeks
Locations
19 sites in 1 country. Site status is shown where the registry gives one.
Retina-Vitreous Associates Medical Group
Beverly Hills, California
California Retina Consultants
Oxnard, California
Retina Institute of California Medical Group d/b/a Acuity Eye Group
Palm Desert, California
Byers Eye Insitute at Stanford
Palo Alto, California
Florida Eye Associates
Melbourne, Florida
Retina Vitreous Assoc of FL
St. Petersburg, Florida
Illinois Retina Associates SC
Oak Park, Illinois
Cumberland Valley Retina PC
Hagerstown, Maryland
Sierra Eye Associates
Reno, Nevada
Wake Forest Baptist Medical Center
Winston-Salem, North Carolina
Cleveland Clinic Foundation
Cleveland, Ohio
Oregon HSU
Portland, Oregon
Mid Atlantic Retina
Philadelphia, Pennsylvania
Retina Res Institute of Texas
Abilene, Texas
Austin Clinical Research LLC
Austin, Texas
Valley Retina Institute P.A.
McAllen, Texas
Medical Center Ophthalmology Associates
San Antonio, Texas
Univ of Virginia Ophthalmology
Charlottesville, Virginia
Karalis Johnson Retina Center
Seattle, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.